Axsome Therapeutics Inc (AXSM)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
10,218,973,000
EV to revenue ratio (TTM)
12.93
EV to ebitda
-14.81
Financial Performance
Revenue (TTM)
776,569,000
Gross profit (TTM)
724,039,000
EBITDA
-172,919,008
Profitability
Operating margin (TTM)
-23.40%
Profit margin
-24.70%
Return on assets (TTM)
-16.30%
Return on equity (TTM)
-245.10%
Per Share Metrics
Revenue per share (TTM)
15.25
EPS
-3.75
Diluted EPS (TTM)
-3.75
Book value
1.59
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
32.15
PEG ratio
0
Price to sales ratio (TTM)
13.16
Price to book ratio (TTM)
121.64
Growth
Quarterly earnings growth (YoY)
45.50%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
3
Buy
17
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.706